Profil
Dr. Jan Kuhlmann Andersen is a Chief Operating Officer at Bioporto A/S and a Chairman at CytoVac AS.
Dr. Andersen was previously employed as a Vice President-Animal Health Sales by Chr.
Hansen Holding A/S.
He also served on the board at Noscomed Medical Supply A/S.
Postes actifs de Jan Kuhlmann Andersen
| Sociétés | Poste | Début |
|---|---|---|
| BIOPORTO A/S | Directeur des opérations | 12/09/2016 |
CytoVac AS
CytoVac AS BiotechnologyHealth Technology Manufactures pharmaceuticals | Président | 01/01/2015 |
Anciens postes connus de Jan Kuhlmann Andersen
| Sociétés | Poste | Fin |
|---|---|---|
| CHRISTIAN HANSEN | Corporate Officer/Principal | 05/11/2012 |
Noscomed Medical Supply A/S | Directeur/Membre du Conseil | 01/01/2015 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Manufactures food cultures, enzymes and nutrition products | Consumer Non-Durables |
CytoVac AS
CytoVac AS BiotechnologyHealth Technology Manufactures pharmaceuticals | Health Technology |
Noscomed Medical Supply A/S |
















